This interview reviews the current challenges to patients and their care teams and highlights how advancing technologies can facilitate the delivery of care.
One such technology is Aptar Pharma’s HeroTracker® Sense. This innovation has the potential to reduce the burden of chronic respiratory diseases on HCPs, nurse practitioners and patients. This novel connected healthcare device transforms a standard metered dose inhaler into a connected healthcare device. It provides valuable feedback to patients to help them use their pMDI as intended and supports their inhalation technique. It also provides valuable analytics to the HCP and insights into patient training and onboarding, thereby helping care teams to better understand real-life situations and use of pMDIs, and adapt treatment plans accordingly.
Learn more about Aptar Pharma’s expertise in Digital Health
This Might Also Be of Interest
Aptar Pharma expert Q&A on digital health and connected drug delivery
Publications, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Device Innovations
The Current State of Play in Connected Devices
Publications, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Device Innovations
Connected Medicine: Insights from Payers and Other Stakeholders
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
Connected Health – An Effective Solution to Improve Patient Adherence
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
